comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Renal effects of receptor in individuals type 2 diabetes: seeds of a promising future | Endocrine Improved Heart and Kidney Outcomes

Garc-Jimnez C, Garcia-Martnez JM, Chocarro-Calvo A, De la Vieja A

The remaining 76 articles underwent a full-text screening process, during which 38 articles were excluded for the following reasons: 4 wrong focus, 13 cells of animal origin and 21 due to an unfitting cell type

This study systematically explored the associations between GLP-1RAs and 12 common psychiatric and neurodevelopmental conditions using large-scale GWAS datasets, revealing protective effects against schizophrenia, anxiety disorders, bipolar disorder, bulimia nervosa, PTSD, and autism, with consistent findings across multiple databases for anxiety disorders, autism, and schizophrenia

Many people also choose to take Alpha Lipoic Acid (ALA) alongside acetyl l-carnitine

What we know NAD biology is well-established, and early human studies show that increasing NAD availability can influence metabolic and mitochondrial markers